Publications

BibTex format

@article{Clough:2020:10.1039/d0dt00332h,
author = {Clough, TJ and Baxan, N and Coakley, EJ and Rivas, C and Zhao, L and Leclerc, I and Martinez-Sanchez, A and Rutter, GA and Long, NJ},
doi = {10.1039/d0dt00332h},
journal = {Dalton Transactions: an international journal of inorganic chemistry},
pages = {4732--4740},
title = {Synthesis and in vivo behaviour of an exendin-4-based MRI probe capable of beta-cell-dependent contrast enhancement in the pancreas},
url = {http://dx.doi.org/10.1039/d0dt00332h},
volume = {49},
year = {2020}
}

Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - Global rates of diabetes mellitus are increasing, and treatment of the disease consumes a growing proportion of healthcare spending across the world. Pancreatic β-cells, responsible for insulin production, decline in mass in type 1 and, to a more limited degree, in type 2 diabetes. However, the extent and rate of loss in both diseases differs between patients resulting in the need for the development of novel diagnostic tools, which could quantitatively assess changes in mass of β-cells over time and potentially lead to earlier diagnosis and improved treatments. Exendin-4, a potent analogue of glucagon-like-peptide 1 (GLP-1), binds to the receptor GLP-1R, whose expression is enriched in β-cells. GLP-1R has thus been used in the past as a means of targeting probes for a wide variety of imaging modalities to the endocrine pancreas. However, exendin-4 conjugates designed specifically for MRI contrast agents are an under-explored area. In the present work, the synthesis and characterization of an exendin-4-dota(ga)-Gd(III) complex, GdEx, is reported, along with its in vivo behaviour in healthy and in β-cell-depleted C57BL/6J mice. Compared to the ubiquitous probe, [Gd(dota)]−, GdEx shows selective uptake by the pancreas with a marked decrease in accumulation observed after the loss of β-cells elicited by deleting the microRNA processing enzyme, DICER. These results open up pathways towards the development of other targeted MRI contrast agents based on similar chemistry methodology.
AU  - Clough,TJ
AU  - Baxan,N
AU  - Coakley,EJ
AU  - Rivas,C
AU  - Zhao,L
AU  - Leclerc,I
AU  - Martinez-Sanchez,A
AU  - Rutter,GA
AU  - Long,NJ
DO  - 10.1039/d0dt00332h
EP  - 4740
PY  - 2020///
SN  - 1477-9226
SP  - 4732
TI  - Synthesis and in vivo behaviour of an exendin-4-based MRI probe capable of beta-cell-dependent contrast enhancement in the pancreas
T2  - Dalton Transactions: an international journal of inorganic chemistry
UR  - http://dx.doi.org/10.1039/d0dt00332h
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000527540400011&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
UR  - https://pubs.rsc.org/en/content/articlelanding/2020/DT/D0DT00332H#!divAbstract
UR  - http://hdl.handle.net/10044/1/84515
VL  - 49
ER  -

Download

ProfessorGuyRutter

Contact

Location

Summary

Citation

BibTex format

RIS format (EndNote, RefMan)